First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates-Reference-Cited by-同舟云学术

First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates

Published:2018-05-10 Issue:6 Volume:7 Page:374-383
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Brussee Janneke M.¹^ORCID,Yu Huixin¹,Krekels Elke H. J.¹^ORCID,de Roos Berend¹,Brill Margreke J. E.²,van den Anker Johannes N.³⁴⁵,Rostami-Hodjegan Amin⁶⁷,de Wildt Saskia N.³⁸,Knibbe Catherijne A. J.¹⁹

Affiliation:

1. Division of Systems Biomedicine and Pharmacology; Leiden Academic Centre for Drug Research (LACDR), Leiden University; Leiden The Netherlands

2. Department of Pharmaceutical Biosciences; Uppsala University; Uppsala Sweden

3. Intensive Care and Department of Pediatric Surgery; Erasmus MC - Sophia Children's Hospital; Rotterdam The Netherlands

4. Division of Paediatric Pharmacology and Pharmacometrics; University of Basel Children's Hospital; Basel Switzerland

5. Division of Clinical Pharmacology; Children's National Health System; Washington DC

6. Centre for Applied Pharmacokinetic Research, University of Manchester; Manchester UK

7. Simcyp Limited (A Certara Company); Sheffield UK

8. Department of Pharmacology and Toxicology; Radboud University Medical Centre; Nijmegen The Netherlands

9. Department of Clinical Pharmacy; St. Antonius Hospital; Nieuwegein The Netherlands

Funder

NWO

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/psp4.12295/fullpdf

Reference48 articles.

1. Impact of developmental pharmacology on pediatric study design: overcoming the challenges;Kearns;J. Allergy Clin. Immunol.,2000

2. Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future;O'Hara;Br. J. Clin. Pharmacol.,2015

3. Determinants of drug metabolism in early neonatal life;Allegaert;Curr. Clin. Pharmacol.,2007

4. Neonatal pharmacology-pharmacokinetics;Johnson;Neonatal Netw.,2011

5. Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children;Johnson;Clin. Pharmacokinet.,2006

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of enteroids derived from children and adults to study age-dependent differences in intestinal CYP3A4/5 metabolism;European Journal of Pharmaceutical Sciences;2024-10

2. Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future;Advanced Drug Delivery Reviews;2024-08

3. Age‐Dependent Abundance of CYP450 Enzymes Involved in Metronidazole Metabolism: Application to Pediatric PBPK Modeling;Clinical Pharmacology & Therapeutics;2024-07-02

4. Developmental pharmacology;Anaesthesia & Intensive Care Medicine;2024-07

5. Combining data on the bioavailability of midazolam and physiologically‐based pharmacokinetic modeling to investigate intestinal CYP3A4 ontogeny;CPT: Pharmacometrics & Systems Pharmacology;2024-06-26